Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Granules Pharmaceuticals' supplemental application for gabapentin to add a granule formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)